Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
This Quarter Return
-2.99%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$52.3B
AUM Growth
+$52.3B
(-7.1%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,741
New
31
Increased
392
Reduced
561
Closed
51
Top Buys
| 1 |
FTAI Aviation
FTAI
|
$141M |
| 2 |
Johnson & Johnson
JNJ
|
$117M |
| 3 |
Atlassian
TEAM
|
$76.6M |
| 4 |
UnitedHealth
UNH
|
$73.4M |
| 5 |
Capital One
COF
|
$71.8M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$302M |
| 2 |
Thermo Fisher Scientific
TMO
|
$143M |
| 3 |
Apple
AAPL
|
$126M |
| 4 |
Meta Platforms (Facebook)
META
|
$85M |
| 5 |
NVIDIA
NVDA
|
$80.5M |
Sector Composition
| 1 | Technology | 27.61% |
| 2 | Financials | 14.61% |
| 3 | Healthcare | 13.57% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Usana Health Sciences
USNA
$583M
| $174K | ﹤0.01% | 6,445 | – | – |
|
1677
Green Plains
GPRE
$728M
| $171K | ﹤0.01% | 35,214 | – | – |
|
1678
Relay Therapeutics
RLAY
$619M
| $170K | ﹤0.01% | 64,900 | – | – |
|
1679
Fluence Energy
FLNC
$969M
| $143K | ﹤0.01% | 29,400 | – | – |
|
1680
Klaviyo
KVYO
$9.73B
| $141K | ﹤0.01% | 4,664 -216 | -4% | -$6.54K |
|
1681
GeneDx Holdings
WGS
$3.72B
| $133K | ﹤0.01% | 1,500 -25,400 | -94% | -$2.25M |
|
1682
Wolfspeed
WOLF
$194M
| $130K | ﹤0.01% | 42,501 | – | – |
|
1683
Quantum Computing Inc
QUBT
$2.52B
| $122K | ﹤0.01% | +15,250 | New | +$122K |
|
1684
Cogent Biosciences
COGT
$1.69B
| $113K | ﹤0.01% | +18,825 | New | +$113K |
|
1685
Arbutus Biopharma
ABUS
$711M
| $76.3K | ﹤0.01% | +21,850 | New | +$76.3K |
|
1686
Genpact
G
$7.9B
| $70.8K | ﹤0.01% | +1,406 | New | +$70.8K |
|
1687
NIO
NIO
$14.3B
| $63K | ﹤0.01% | 16,526 -845 | -5% | -$3.22K |
|
|
OKLO
1688
Oklo
OKLO
$10.9B
| $32.4K | ﹤0.01% | +1,500 | New | +$32.4K |
|
1689
Sterling Infrastructure
STRL
$8.47B
| – | – | -635 | Closed | -$107K |
|
1690
Altimmune
ALT
$338M
| – | – | -454,981 | Closed | -$3.28M |
|
1691
Apogee Therapeutics
APGE
$2.17B
| – | – | -69,750 | Closed | -$3.16M |
|
1692
Aura Biosciences
AURA
$389M
| – | – | -390,695 | Closed | -$3.21M |
|
1693
Beyond Meat
BYND
$192M
| – | – | -40,493 | Closed | -$152K |
|
|
CLDT
1694
Chatham Lodging
CLDT
$374M
| – | – | -47,551 | Closed | -$426K |
|
|
CRGX
1695
DELISTED
CARGO Therapeutics
CRGX
| – | – | -50,000 | Closed | -$721K |
|
1696
Dine Brands
DIN
$368M
| – | – | -15,448 | Closed | -$465K |
|
|
DNB
1697
DELISTED
Dun & Bradstreet
DNB
| – | – | -84,545 | Closed | -$1.05M |
|
|
ETWO
1698
DELISTED
E2open Parent Holdings
ETWO
| – | – | -165,400 | Closed | -$440K |
|
1699
Edgewise Therapeutics
EWTX
$1.51B
| – | – | -80,509 | Closed | -$2.15M |
|
1700
Structure Therapeutics
GPCR
$1.11B
| – | – | -308,241 | Closed | -$8.36M |
|